AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication

NCT06614049 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2024-10-03

No results posted yet for this study

Summary

Investigators hypothesize that the use of a human coach-supported digital/AI personal health assistant (app) will improve adherence to cholesterol-lowering medications (statins with or without ezetimibe) among patients with hyperlipidaemia and suboptimal LDL-C control, when compared to standard care.

Conditions

Interventions

BEHAVIORAL

Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medications

Receive personalised feedback and educational content curated by local clinicians and pharmacists through the CADENCE D-PHA app coupled with six sessions of human coaching on top of usual clinical care for lipid management over 6 months

Sponsors & Collaborators

  • National University Polyclinics, Singapore

    collaborator OTHER
  • Nanyang Technological University

    collaborator OTHER
  • National Healthcare Group Polyclinics

    collaborator OTHER_GOV
  • Consortium for Clinical Research and Innovation, Singapore (CRIS)

    collaborator UNKNOWN
  • National University Heart Centre, Singapore

    collaborator OTHER
  • National University of Singapore

    lead OTHER

Principal Investigators

  • Ying Xian Chua · National University Polyclinics

  • Ziliang Lim · National Healthcare Group Polyclinics

  • Andy Khong · Nanyang Technological University

  • Andy Hau Yan Ho · Nanyang Technological University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-10
Primary Completion
2026-02-14
Completion
2026-02-14

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614049 on ClinicalTrials.gov